Further evidence for the role of CXCL12 in T-cell infiltration came from other preclinical studies, where inhibition of CXCR4 (the receptor for CXCL12) enhanced the response to checkpoint inhibition in a pancreatic cancer model (73). The gene discussed is CXCL12; the disease is pancreatic neoplasm.